Newsroom

Recent News Releases

May 19, 2019 5/19/2019 New Exploratory Data from VARSITY, the First Head-to-Head Ulcerative Colitis Biologic Study Which Demonstrated Superiority of Vedolizumab to Adalimumab in Clinical Remission at Week 52, Presented at 2019 Digestive Disease Week^®

May 16, 2019 5/16/2019 Takeda to Showcase Growing Pipeline and Diversified Portfolio of Oncology Products at Upcoming Scientific Congresses

May 16, 2019 5/16/2019 Takeda and London School of Hygiene & Tropical Medicine Establish "Takeda Chair in Global Child Health"

May 15, 2019 5/15/2019 Takeda to Highlight New Research into the Long-term Complications of Chronic Hypoparathyroidism at the European Congress of Endocrinology 2019 Annual Meeting

May 14, 2019 5/14/2019 Continuation of and Partial Revisions to the Long-Term Incentive Plan for Members of the Board of Directors in Fiscal 2019

SEE ALL NEWS AND RELEASES >

・For legacy Shire information, click here

Featured Topics

Deepening Our Commitment to Research with State-of-the-Art Facility in San Diego, California

LEARN MORE

2019 Innovators in Science Award Winners Celebrated for Regenerative Medicine Research

LEARN MORE

CEO Christophe Weber on Why Takeda’s Unique Corporate Governance Structure Works

LEARN MORE

Andy Plump on pushing the boundaries of science within the “new” Takeda R&D community

LEARN MORE

Ramona Sequeira, President of Takeda's U.S. Business Unit, on the many opportunities that lie ahead for the “new” Takeda

LEARN MORE

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.